Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Commentary: To win the biotech battle, we don’t need entirely new strategies. We just need to avoid self-destructive policies ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and biotechnology industries think about drug development, regenerative medicine, ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...